The Institute of Pharmaceutical Innovation

Sunday 26th October, 2003 Institute Appoints First Senior Scientist

The IPI, opened by Science Minister Lord Sainsbury in October 2003, will use the latest artificial intelligence and computer simulation technology together with advanced analytical techniques to predict how drugs will behave in the human body and to research new methods for the development of better drugs.

Dr Leusen said: “I am hugely excited at having this opportunity. The IPI is the perfect vehicle with which we can push to a higher level the understanding of drugs development.”

IPI Director Paul Thorning said: “We feel that Frank Leusen is a real catch for the IPI. He is one of a leading group of scientists who have pioneered the molecular modelling approach to pharmaceutical development which is a key part of the Institute’s research and development role.”

As Principal Research Fellow at the University of Bradford since January 2003, Dr Leusen helped in the development of the IPI before its launch.

Dr Leusen is an acknowledged expert in using computers to simulate and predict crystal structures, which form the basis of most drugs.

From 1982 to 1988 he studied pharmacy and bio-pharmaceutical sciences at Leiden University in the Netherlands, before taking a PhD in Chemistry at Nijmegen University.

IPI Building detail.He worked as a consultant and researcher for Novartis AG in Switzerland before joining Accelrys Inc (formerly Molecular Simulations Inc) in Cambridge in 1993.

While there he co-ordinated the development of technology for the prediction of crystal structures.

He also founded the Pharmaceutical Development Consortium – a collaboration between industry, academic advisors and internal R and D scientists.
Media note:

There is a photograph of Frank Leusen and of the IPI available from the Press Office. Please see the contact details below.

General University Press contacts

For further information, please contact Emma Scales in Corporate Communications on (01274) 233084/9 or 07879 437986. Alternatively, e-mail or fax on (01274) 236280.